Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Moore

Showing results (1121-1130 of 1,231) with videos related to

Pageof 124
Sort By:
Journal of Environmental Management|March 23, 2023
Rapid prototyping for quantifying belief weights of competing hypotheses about emergent diseasesEllen P Robertson, Daniel P Walsh, Julien Martin, et al.
Nature Medicine|October 6, 2020
Continuous versus intermittent BRAF and MEK inhibition in patients with BRAF-mutated melanoma: a randomized phase 2 trialAlain P Algazi, Megan Othus, Adil I Daud, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 3, 2018
Gonadotropin-Releasing Hormone Agonists During Chemotherapy for Preservation of Ovarian Function and Fertility in Premenopausal Patients With Early Breast Cancer: A Systematic Review and Meta-Analysis of Individual Patient-Level DataMatteo Lambertini, Halle C F Moore, Robert C F Leonard, et al.
Life Sciences in Space Research|May 14, 2018
Solar particle event storm shelter requirements for missions beyond low Earth orbitL W Townsend, J H Adams, S R Blattnig, et al.
JCO Clinical Cancer Informatics|June 23, 2023
Operational Metrics for the ELAINE 2 Study Combining a Traditional Approach With a Just-in-TIME ModelSibel Blau, Julio Antonio Peguero, Halle C F Moore, et al.
The Journal of Clinical Investigation|March 12, 2026
Inhibiting LSD1 unlocks retinoid AP-1 programming to activate epithelial immunity and skin tumor suppressionNina Kuprasertkul, Alyssa F Moore, Carina A D'souza, et al.
Mitochondrion|May 26, 2024
ACAD9 treatment with bezafibrate and nicotinamide riboside temporarily stabilizes cardiomyopathy and lactic acidosisJohan L K Van Hove, Marisa W Friederich, Daniella H Hock, et al.
JAMA Network Open|May 4, 2023
Adherence to Cancer Prevention Lifestyle Recommendations Before, During, and 2 Years After Treatment for High-risk Breast CancerRikki A Cannioto, Kristopher M Attwood, Evan W Davis, et al.
Cancers|August 12, 2023
Cell State and Cell Type: Deconvoluting Circulating Tumor Cell Populations in Liquid Biopsies by Multi-OmicsLisa Welter, Serena Zheng, Sonia Maryam Setayesh, et al.
Neuro-Oncology|October 11, 2017
Phase I/II trial of vorinostat combined with temozolomide and radiation therapy for newly diagnosed glioblastoma: results of Alliance N0874/ABTC 02Evanthia Galanis, S Keith Anderson, C Ryan Miller, et al.
Pageof 124

Showing results (1121-1130 of 1,231) with videos related to

Sort By:
Pageof 124
Journal of Environmental Management|March 23, 2023
Rapid prototyping for quantifying belief weights of competing hypotheses about emergent diseasesEllen P Robertson, Daniel P Walsh, Julien Martin, et al.
Nature Medicine|October 6, 2020
Continuous versus intermittent BRAF and MEK inhibition in patients with BRAF-mutated melanoma: a randomized phase 2 trialAlain P Algazi, Megan Othus, Adil I Daud, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 3, 2018
Gonadotropin-Releasing Hormone Agonists During Chemotherapy for Preservation of Ovarian Function and Fertility in Premenopausal Patients With Early Breast Cancer: A Systematic Review and Meta-Analysis of Individual Patient-Level DataMatteo Lambertini, Halle C F Moore, Robert C F Leonard, et al.
Life Sciences in Space Research|May 14, 2018
Solar particle event storm shelter requirements for missions beyond low Earth orbitL W Townsend, J H Adams, S R Blattnig, et al.
JCO Clinical Cancer Informatics|June 23, 2023
Operational Metrics for the ELAINE 2 Study Combining a Traditional Approach With a Just-in-TIME ModelSibel Blau, Julio Antonio Peguero, Halle C F Moore, et al.
The Journal of Clinical Investigation|March 12, 2026
Inhibiting LSD1 unlocks retinoid AP-1 programming to activate epithelial immunity and skin tumor suppressionNina Kuprasertkul, Alyssa F Moore, Carina A D'souza, et al.
Mitochondrion|May 26, 2024
ACAD9 treatment with bezafibrate and nicotinamide riboside temporarily stabilizes cardiomyopathy and lactic acidosisJohan L K Van Hove, Marisa W Friederich, Daniella H Hock, et al.
JAMA Network Open|May 4, 2023
Adherence to Cancer Prevention Lifestyle Recommendations Before, During, and 2 Years After Treatment for High-risk Breast CancerRikki A Cannioto, Kristopher M Attwood, Evan W Davis, et al.
Cancers|August 12, 2023
Cell State and Cell Type: Deconvoluting Circulating Tumor Cell Populations in Liquid Biopsies by Multi-OmicsLisa Welter, Serena Zheng, Sonia Maryam Setayesh, et al.
Neuro-Oncology|October 11, 2017
Phase I/II trial of vorinostat combined with temozolomide and radiation therapy for newly diagnosed glioblastoma: results of Alliance N0874/ABTC 02Evanthia Galanis, S Keith Anderson, C Ryan Miller, et al.
Pageof 124